世界の神経インターベンション装置開発動向:医療機器パイプライン分析2015

◆英語タイトル:Interventional Neurology - Medical Devices Pipeline Assessment, 2015
◆商品コード:GDME0132EPD
◆発行会社(調査会社):GlobalData
◆発行日:2016年1月1日
◆ページ数:192
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥408,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD8,000 ⇒換算¥816,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD12,000 ⇒換算¥1,224,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。



当調査レポートでは、神経インターベンション装置のグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。

・神経インターベンション装置の概要
・神経インターベンション装置の開発動向:開発段階別分析
・神経インターベンション装置の開発動向:セグメント別分析
・神経インターベンション装置の開発動向:領域別分析
・神経インターベンション装置の開発動向:規制Path別分析
・神経インターベンション装置の開発動向:承認日(推定)別分析
・企業別神経インターベンション装置の開発動向(パイプライン製品、進行中の治験)
・神経インターベンション装置の最近動向
【レポートの概要】

Interventional Neurology – Medical Devices Pipeline Assessment, 2015

Summary

GlobalData’s Medical Devices sector report, “Interventional Neurology – Medical Devices Pipeline Assessment, 2015″ provides an overview of Interventional Neurology currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Interventional Neurology pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Interventional Neurology under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Interventional Neurology and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Interventional Neurology under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 12
2 Introduction 13
2.1 Interventional Neurology Overview 13
3 Products under Development 14
3.1 Interventional Neurology – Pipeline Products by Stage of Development 14
3.2 Interventional Neurology – Pipeline Products by Segment 15
3.3 Interventional Neurology – Pipeline Products by Territory 17
3.4 Interventional Neurology – Pipeline Products by Regulatory Path 18
3.5 Interventional Neurology – Pipeline Products by Estimated Approval Date 19
3.6 Interventional Neurology – Ongoing Clinical Trials 20
4 Interventional Neurology – Pipeline Products under Development by Companies 21
4.1 Interventional Neurology Companies – Pipeline Products by Stage of Development 21
4.2 Interventional Neurology – Pipeline Products by Stage of Development 24
5 Interventional Neurology Companies and Product Overview 27
5.1 Alcyone Lifesciences, Inc. Company Overview 27
5.1.1 Alcyone Lifesciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.2 Aneuclose LLC Company Overview 28
5.2.1 Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview 28
5.3 Apeliotus Technologies Company Overview 30
5.3.1 Apeliotus Technologies Pipeline Products & Ongoing Clinical Trials Overview 30
5.4 Arterain Medical Inc. Company Overview 31
5.4.1 Arterain Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
5.5 Avantec Vascular Corporation Company Overview 32
5.5.1 Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview 32
5.6 Cibiem, Inc. Company Overview 34
5.6.1 Cibiem, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
5.7 Codman & Shurtleff, Inc. Company Overview 37
5.7.1 Codman & Shurtleff, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
5.8 Collagen Matrix, Inc. Company Overview 39
5.8.1 Collagen Matrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 39
5.9 Cordis Corporation Company Overview 40
5.9.1 Cordis Corporation Pipeline Products & Ongoing Clinical Trials Overview 40
5.10 CranioVation Company Overview 42
5.10.1 CranioVation Pipeline Products & Ongoing Clinical Trials Overview 42
5.11 Dartmouth College Company Overview 43
5.11.1 Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview 43
5.12 DePuy Companies Company Overview 45
5.12.1 DePuy Companies Pipeline Products & Ongoing Clinical Trials Overview 45
5.13 EchoGuide Medical, Inc. Company Overview 55
5.13.1 EchoGuide Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.14 EKOS Corporation Company Overview 56
5.14.1 EKOS Corporation Pipeline Products & Ongoing Clinical Trials Overview 56
5.15 Gaudi Vascular, Inc. Company Overview 57
5.15.1 Gaudi Vascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
5.16 Hansjorg Wyss Institute for Biologically Inspired Engineering Company Overview 59
5.16.1 Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview 59
5.17 Hibernia Medical Company Overview 61
5.17.1 Hibernia Medical Pipeline Products & Ongoing Clinical Trials Overview 61
5.18 Insera Therapeutics, LLC Company Overview 62
5.18.1 Insera Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 62
5.19 InspireMD, Inc. Company Overview 64
5.19.1 InspireMD, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
5.20 ITGI Medical Ltd. Company Overview 66
5.20.1 ITGI Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 66
5.21 Lazarus Effect, Inc Company Overview 67
5.21.1 Lazarus Effect, Inc Pipeline Products & Ongoing Clinical Trials Overview 67
5.22 Medikit Co., Ltd. Company Overview 70
5.22.1 Medikit Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 70
5.23 Merlin MD Pte. Ltd. Company Overview 75
5.23.1 Merlin MD Pte. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 75
5.24 Metactive Medical, LLC Company Overview 77
5.24.1 Metactive Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 77
5.25 MicroPort Scientific Corporation Company Overview 78
5.25.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 78
5.26 MicroVention, Inc. Company Overview 82
5.26.1 MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview 82
5.27 MindFrame Inc. (Inactive) Company Overview 84
5.27.1 MindFrame Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 84
5.28 Neuravi Limited Company Overview 85
5.28.1 Neuravi Limited Pipeline Products & Ongoing Clinical Trials Overview 85
5.29 NeuroInterventional Therapeutics, Inc. Company Overview 88
5.29.1 NeuroInterventional Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 88
5.30 NeuroInterventions Company Overview 89
5.30.1 NeuroInterventions Pipeline Products & Ongoing Clinical Trials Overview 89
5.31 NeuroSigma, Inc. Company Overview 90
5.31.1 NeuroSigma, Inc. Pipeline Products & Ongoing Clinical Trials Overview 90
5.32 Neurosyntec LLC. Company Overview 91
5.32.1 Neurosyntec LLC. Pipeline Products & Ongoing Clinical Trials Overview 91
5.33 NexGen Medical Systems, Inc. Company Overview 94
5.33.1 NexGen Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 94
5.34 NSVascular, Inc. Company Overview 95
5.34.1 NSVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 95
5.35 Palmaz Scientific, Inc. Company Overview 97
5.35.1 Palmaz Scientific, Inc. Pipeline Products & Ongoing Clinical Trials Overview 97
5.36 Penumbra, Inc. Company Overview 98
5.36.1 Penumbra, Inc. Pipeline Products & Ongoing Clinical Trials Overview 98
5.37 Philips Healthcare Company Overview 100
5.37.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 100
5.38 PhotoThera, Inc. Company Overview 102
5.38.1 PhotoThera, Inc. Pipeline Products & Ongoing Clinical Trials Overview 102
5.39 Pulsar Vascular, Inc. Company Overview 110
5.39.1 Pulsar Vascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 110
5.40 Pulse Therapeutics, Inc. Company Overview 111
5.40.1 Pulse Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 111
5.41 Rapid Medical Company Overview 112
5.41.1 Rapid Medical Pipeline Products & Ongoing Clinical Trials Overview 112
5.42 Reverse Medical Corporation Company Overview 113
5.42.1 Reverse Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 113
5.43 Rontis AG Company Overview 116
5.43.1 Rontis AG Pipeline Products & Ongoing Clinical Trials Overview 116
5.44 Sequent Medical, Inc. Company Overview 117
5.44.1 Sequent Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 117
5.45 Shape Memory Therapeutics, Inc. Company Overview 121
5.45.1 Shape Memory Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 121
5.46 Silk Road Medical, Inc. Company Overview 123
5.46.1 Silk Road Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 123
5.47 Strategic Polymer Sciences, Inc Company Overview 127
5.47.1 Strategic Polymer Sciences, Inc Pipeline Products & Ongoing Clinical Trials Overview 127
5.48 Stryker Corporation Company Overview 128
5.48.1 Stryker Corporation Pipeline Products & Ongoing Clinical Trials Overview 128
5.49 Synaptive Medical Inc. Company Overview 133
5.49.1 Synaptive Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 133
5.50 Terumo Corporation Company Overview 137
5.50.1 Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview 137
5.51 Triticum Medical Ltd. Company Overview 139
5.51.1 Triticum Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 139
5.52 Twin Star Medical, Inc. Company Overview 140
5.52.1 Twin Star Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 140
5.53 University of California, San Francisco Company Overview 142
5.53.1 University of California, San Francisco Pipeline Products & Ongoing Clinical Trials Overview 142
5.54 University of Oxford Company Overview 144
5.54.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 144
5.55 University of South Florida Company Overview 145
5.55.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 145
5.56 University of Wisconsin Madison Company Overview 147
5.56.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 147
5.57 University of Wolverhampton Company Overview 150
5.57.1 University of Wolverhampton Pipeline Products & Ongoing Clinical Trials Overview 150
5.58 Valor Medical, Inc. Company Overview 151
5.58.1 Valor Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 151
5.59 Vascular Solutions, Inc. Company Overview 152
5.59.1 Vascular Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 152
5.60 Viket Medical Corporation Company Overview 154
5.60.1 Viket Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 154
5.61 Zoll Medical Corporation Company Overview 155
5.61.1 Zoll Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 155
6 Interventional Neurology- Recent Developments 157
7 Appendix 189
7.1 Methodology 189
7.2 About GlobalData 191
7.3 Contact Us 192
7.4 Disclaimer 192

1.1 List of Tables
Table 1: Interventional Neurology - Pipeline Products by Stage of Development 14
Table 2: Interventional Neurology - Pipeline Products by Segment 16
Table 3: Interventional Neurology - Pipeline Products by Territory 17
Table 4: Interventional Neurology - Pipeline Products by Regulatory Path 18
Table 5: Interventional Neurology - Pipeline Products by Estimated Approval Date 19
Table 6: Interventional Neurology - Ongoing Clinical Trials 20
Table 7: Interventional Neurology Companies - Pipeline Products by Stage of Development 21
Table 8: Interventional Neurology - Pipeline Products by Stage of Development 24
Table 9: Alcyone Lifesciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
Table 10: Alcyone Microcatheter - Product Status 27
Table 11: Alcyone Microcatheter - Product Description 27
Table 12: Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview 28
Table 13: Aneurysm Occlusion Saddle - Product Status 28
Table 14: Aneurysm Occlusion Saddle - Product Description 28
Table 15: Janjua Aneurysm Net - Product Status 29
Table 16: Janjua Aneurysm Net - Product Description 29
Table 17: Apeliotus Technologies Pipeline Products & Ongoing Clinical Trials Overview 30
Table 18: Polymer Stent for Cerebral Aneurysms - Product Status 30
Table 19: Polymer Stent for Cerebral Aneurysms - Product Description 30
Table 20: Arterain Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
Table 21: Catheter Based System - Product Status 31
Table 22: Catheter Based System - Product Description 31
Table 23: Avantec Vascular Corporation Pipeline Products & Ongoing Clinical Trials Overview 32
Table 24: Endovascular Embolization Device - Product Status 32
Table 25: Endovascular Embolization Device - Product Description 32
Table 26: Ischemic Stroke Therapy Device - Product Status 33
Table 27: Ischemic Stroke Therapy Device - Product Description 33
Table 28: Cibiem, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
Table 29: Carotid Body Modulation - Product Status 34
Table 30: Carotid Body Modulation - Product Description 34
Table 31: Cibiem, Inc. - Ongoing Clinical Trials Overview 35
Table 32: Carotid Body Modulation - Endovascular Carotid Body Ablation in Patients with Treatment- resistant Hypertension: A Safety and Feasibility Study 36
Table 33: Codman & Shurtleff, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
Table 34: Next Generation REVIVE SE - Product Status 38
Table 35: Next Generation REVIVE SE - Product Description 38
Table 36: Collagen Matrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 39
Table 37: Collagen-based Coils - Product Status 39
Table 38: Collagen-based Coils - Product Description 39
Table 39: Cordis Corporation Pipeline Products & Ongoing Clinical Trials Overview 40
Table 40: Flow Diverter - Product Status 41
Table 41: Flow Diverter - Product Description 41
Table 42: CranioVation Pipeline Products & Ongoing Clinical Trials Overview 42
Table 43: Brain Aneurysm Clip - Product Status 42
Table 44: Brain Aneurysm Clip - Product Description 42
Table 45: Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview 43
Table 46: Aneurysm Clip Applicator - Product Status 43
Table 47: Aneurysm Clip Applicator - Product Description 43
Table 48: Cerebral Aneurysm Clip - Product Status 44
Table 49: Cerebral Aneurysm Clip - Product Description 44
Table 50: DePuy Companies Pipeline Products & Ongoing Clinical Trials Overview 45
Table 51: Covered Stent - Product Status 46
Table 52: Covered Stent - Product Description 46
Table 53: Liquid Embolic System - Product Status 47
Table 54: Liquid Embolic System - Product Description 47
Table 55: Next Generation Balloon Expandable Stent - Product Status 48
Table 56: Next Generation Balloon Expandable Stent - Product Description 48
Table 57: Occlusion Balloons - Product Status 49
Table 58: Occlusion Balloons - Product Description 49
Table 59: PHAROS Vitesse Stent - Product Status 50
Table 60: PHAROS Vitesse Stent - Product Description 50
Table 61: REVIVE SE - Product Status 51
Table 62: REVIVE SE - Product Description 51
Table 63: Self-Expanding Stent - Product Status 52
Table 64: Self-Expanding Stent - Product Description 52
Table 65: DePuy Companies - Ongoing Clinical Trials Overview 53
Table 66: PHAROS Vitesse Stent - Phase III Study of Pharos Vitesse Neurovascular Stent System Compared to Best Medical Therapy for the Treatment of Ischemic Disease 54
Table 67: EchoGuide Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
Table 68: Ultrasound Catheter Navigation Device - Product Status 55
Table 69: Ultrasound Catheter Navigation Device - Product Description 55
Table 70: EKOS Corporation Pipeline Products & Ongoing Clinical Trials Overview 56
Table 71: EKOS EkoSonic SV System - Neuro Vasculature - Product Status 56
Table 72: EKOS EkoSonic SV System - Neuro Vasculature - Product Description 56
Table 73: Gaudi Vascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
Table 74: Intracranial Stent - Product Status 57
Table 75: Intracranial Stent - Product Description 57
Table 76: Zippered Microcatheter - Product Status 58
Table 77: Zippered Microcatheter - Product Description 58
Table 78: Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview 59
Table 79: Blood Clots Clearing Device - Product Status 60
Table 80: Blood Clots Clearing Device - Product Description 60
Table 81: Hibernia Medical Pipeline Products & Ongoing Clinical Trials Overview 61
Table 82: Hybernia Safety Catheter - Neuroprotection - Product Status 61
Table 83: Hybernia Safety Catheter - Neuroprotection - Product Description 61
Table 84: Insera Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 62
Table 85: SHELTER - Product Status 63
Table 86: SHELTER - Product Description 63
Table 87: InspireMD, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
Table 88: NVGuard Neurovascular - Product Status 65
Table 89: NVGuard Neurovascular - Product Description 65
Table 90: ITGI Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 66
Table 91: Mechanical Thrombectomy Device - Product Status 66
Table 92: Mechanical Thrombectomy Device - Product Description 66
Table 93: Lazarus Effect, Inc Pipeline Products & Ongoing Clinical Trials Overview 67
Table 94: Lazarus Cover - Product Status 67
Table 95: Lazarus Cover - Product Description 67
Table 96: Lazarus Lynx - Product Status 68
Table 97: Lazarus Lynx - Product Description 68
Table 98: Lazarus ReCover - Product Status 69
Table 99: Lazarus ReCover - Product Description 69
Table 100: Medikit Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 70
Table 101: Aspirarecath - Product Status 71
Table 102: Aspirarecath - Product Description 71
Table 103: Axcelguide - Product Status 72
Table 104: Axcelguide - Product Description 72
Table 105: Cerulean G - Product Status 73
Table 106: Cerulean G - Product Description 73
Table 107: Slimguide - Product Status 74
Table 108: Slimguide - Product Description 74
Table 109: Merlin MD Pte. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 75
Table 110: Next Generation Device For Cerebral Aneurysm - Product Status 75
Table 111: Next Generation Device For Cerebral Aneurysm - Product Description 75
Table 112: X Calibur Aneurysm Occlusion Device - Product Status 76
Table 113: X Calibur Aneurysm Occlusion Device - Product Description 76
Table 114: Metactive Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 77
Table 115: Ballstent Microcatheter - Product Status 77
Table 116: Ballstent Microcatheter - Product Description 77
Table 117: MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 78
Table 118: Blood Clot Removing Device - Product Status 79
Table 119: Blood Clot Removing Device - Product Description 79
Table 120: Micro-Catheter - Product Status 80
Table 121: Micro-Catheter - Product Description 80
Table 122: Tubridge - Product Status 81
Table 123: Tubridge - Product Description 81
Table 124: MicroVention, Inc. Pipeline Products & Ongoing Clinical Trials Overview 82
Table 125: ERIC Clot Removal Device - Product Status 82

1.2 List of Figures
Figure 1: Interventional Neurology - Pipeline Products by Stage of Development 14
Figure 2: Interventional Neurology - Pipeline Products by Segment 15
Figure 3: Interventional Neurology - Pipeline Products by Territory 17
Figure 4: Interventional Neurology - Pipeline Products by Regulatory Path 18
Figure 5: Interventional Neurology - Pipeline Products by Estimated Approval Date 19
Figure 6: Interventional Neurology - Ongoing Clinical Trials 20

【掲載企業】

Alcyone Lifesciences, Inc.
Aneuclose LLC
Apeliotus Technologies
Arterain Medical Inc.
Avantec Vascular Corporation
Cibiem, Inc.
Codman & Shurtleff, Inc.
Collagen Matrix, Inc.
Cordis Corporation
CranioVation
Dartmouth College
DePuy Companies
EchoGuide Medical, Inc.
EKOS Corporation
Gaudi Vascular, Inc.
Hansjorg Wyss Institute for Biologically Inspired Engineering
Hibernia Medical
Insera Therapeutics, LLC
InspireMD, Inc.
ITGI Medical Ltd.
Lazarus Effect, Inc
Medikit Co., Ltd.
Merlin MD Pte. Ltd.
Metactive Medical, LLC
MicroPort Scientific Corporation
MicroVention, Inc.
MindFrame Inc. (Inactive)
Neuravi Limited
NeuroInterventional Therapeutics, Inc.
NeuroInterventions
NeuroSigma, Inc.
Neurosyntec LLC.
NexGen Medical Systems, Inc.
NSVascular, Inc.
Palmaz Scientific, Inc.
Penumbra, Inc.
Philips Healthcare
PhotoThera, Inc.
Pulsar Vascular, Inc.
Pulse Therapeutics, Inc.
Rapid Medical
Reverse Medical Corporation
Rontis AG
Sequent Medical, Inc.
Shape Memory Therapeutics, Inc.
Silk Road Medical, Inc.
Strategic Polymer Sciences, Inc
Stryker Corporation
Synaptive Medical Inc.
Terumo Corporation
Triticum Medical Ltd.
Twin Star Medical, Inc.
University of California, San Francisco
University of Oxford
University of South Florida
University of Wisconsin Madison
University of Wolverhampton
Valor Medical, Inc.
Vascular Solutions, Inc.
Viket Medical Corporation
Zoll Medical Corporation

【レポートのキーワード】

神経インターベンション装置

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[世界の神経インターベンション装置開発動向:医療機器パイプライン分析2015]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。H&I文字はH&Iグローバルリサーチ株式会社の商標(登録第5783645号)です。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。
※当サイトでは2016年06月28日現在 193,799 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆